Neil Poulter Selected Research

perindopril drug combination indapamide

1/2021	The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.
1/2021	History of lower-limb complications and risk of cancer death in people with type 2 diabetes.
1/2020	Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial.
1/2020	Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.
1/2019	Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
1/2018	Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
1/2018	Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
1/2018	Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
1/2018	Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.
1/2017	Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Poulter Research Topics

Disease

47	Type 2 Diabetes Mellitus (MODY) 02/2021 - 06/2008
38	Vascular Diseases (Vascular Disease) 01/2021 - 04/2009
23	Hypertension (High Blood Pressure) 12/2021 - 01/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 11/2010
8	Stroke (Strokes) 01/2018 - 07/2004
7	Myocardial Infarction 06/2017 - 07/2004
4	Diabetes Mellitus 01/2019 - 12/2013
3	Genetic Risk Score 10/2021 - 03/2017
3	Diabetes Complications 10/2021 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 03/2013
3	Coronary Disease (Coronary Heart Disease) 12/2013 - 12/2006
2	Heart Diseases (Heart Disease) 12/2021 - 12/2016
2	Kidney Diseases (Kidney Disease) 02/2021 - 05/2016
2	Body Weight (Weight, Body) 01/2019 - 04/2016
2	Erectile Dysfunction 06/2017 - 11/2010
2	Heart Failure 01/2016 - 12/2013
2	Blindness (Hysterical Blindness) 01/2016 - 01/2016
2	Albuminuria 03/2013 - 11/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021
1	Necrosis 02/2021
1	Frailty 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Atrial Fibrillation 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017
1	beta-Thalassemia (Cooley's Anemia) 12/2017
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Insulin Resistance 11/2017
1	Weight Loss (Weight Reduction) 11/2017
1	Hemic and Lymphatic Diseases 06/2017
1	Hypotension (Low Blood Pressure) 01/2017

Drug/Important Bio-Agent (IBA)

38	Gliclazide (Diamicron)IBA 01/2021 - 06/2008
37	perindopril drug combination indapamideIBA 01/2021 - 04/2009
15	Perindopril FDA LinkGeneric 01/2019 - 04/2009
13	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 06/2008
11	Indapamide FDA LinkGeneric 01/2019 - 04/2009
10	Antihypertensive Agents (Antihypertensives)IBA 08/2020 - 01/2004
8	Pharmaceutical PreparationsIBA 12/2021 - 01/2015
7	CreatinineIBA 01/2019 - 11/2012
6	LipidsIBA 12/2021 - 12/2006
6	Biomarkers (Surrogate Marker)IBA 02/2021 - 06/2009
5	Atorvastatin (Lipitor)FDA Link 01/2018 - 12/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2012
5	CholesterolIBA 06/2017 - 01/2011
4	Amlodipine (Norvasc)FDA LinkGeneric 01/2019 - 12/2006
3	LDL CholesterolIBA 12/2021 - 11/2016
3	Exenatide (Byetta)FDA Link 05/2017 - 04/2016
3	Retinaldehyde (Retinal)IBA 01/2016 - 06/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2015 - 01/2014
3	Troponin T (Troponin T1)IBA 07/2015 - 01/2014
2	Biological ProductsIBA 12/2021 - 03/2017
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2019 - 01/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2016
2	Atenolol (Tenormin)FDA LinkGeneric 01/2018 - 12/2006
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018 - 02/2014
2	Hormones (Hormone)IBA 11/2017 - 07/2004
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2014 - 06/2008
2	pro-brain natriuretic peptide (1-76)IBA 08/2014 - 01/2014
2	C-Reactive ProteinIBA 03/2014 - 06/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 01/2011
1	Bone Morphogenetic Protein 7IBA 02/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2021
1	AntibodiesIBA 02/2021
1	Neoplasm AntibodiesIBA 02/2021
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 02/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2021
1	AutoantibodiesIBA 02/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	PotassiumIBA 01/2020
1	SodiumIBA 01/2020
1	Liraglutide FDA Link 01/2019
1	HDL CholesterolIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Anti-Arrhythmia AgentsIBA 01/2019
1	IDegLiraIBA 01/2019
1	insulin degludecIBA 01/2019
1	AlbuminsIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 12/2017
1	oxidized low density lipoproteinIBA 12/2017
1	Bile Acids and Salts (Bile Acids)IBA 11/2017
1	Fibric Acids (Fibrates)IBA 06/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	NitratesIBA 12/2016

Therapy/Procedure

12	Therapeutics 01/2021 - 05/2012
6	Glycemic Control 01/2020 - 06/2008
2	Drug Therapy (Chemotherapy) 12/2019 - 11/2014
2	Kidney Transplantation 05/2016 - 03/2013
2	Surgical Amputation (Amputations) 01/2016 - 01/2016
1	Chronotherapy 01/2020
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2017
1	Bariatric Surgery 11/2017
1	Precision Medicine 03/2017
1	Subcutaneous Injections 01/2017
1	Percutaneous Coronary Intervention 12/2016